Back to Search
Start Over
Development of quality measures for use of self-injectable biologic therapy in inflammatory bowel disease: An integrated specialty pharmacy initiative
- Source :
- American Journal of Health-System Pharmacy. 76:1296-1304
- Publication Year :
- 2019
- Publisher :
- Oxford University Press (OUP), 2019.
-
Abstract
- PurposeThe development of a tool to measure medication safety, therapeutic efficacy, and other quality outcomes in patients receiving self-injectable biologic therapy for the management of inflammatory bowel disease (IBD) at a health-system specialty pharmacy is described.SummaryThrough a collaborative initiative by pharmacists, gastro-enterologists, and representatives of a pharmacy benefit manager and a pharmaceutical company, a set of clinical and specialty pharmacy quality measures was developed. The clinical measures are intended for use in assessing patient safety, disease status, treatment efficacy, and healthcare resource utilization during 3 assessments (pre-treatment, on-treatment, and longitudinal). The specialty pharmacy measures can be used to assess medication adherence, medication persistence, specialty pharmacy accreditation, and patient satisfaction. The proposed quality measures provide a foundation for evaluating the quality of IBD care and improving patient outcomes within a health-system specialty pharmacy. Future efforts to validate and implement the tool in clinical practice are planned.ConclusionThe proposed quality measures provide a foundation for future inquiry regarding the appropriateness and feasibility of integrating the measures into clinical care. Further work is needed to implement and validate these quality measures and determine their impact in optimizing health outcomes.
- Subjects :
- medicine.medical_specialty
Drug Industry
media_common.quotation_subject
Self Administration
Pharmacy
Pharmacists
03 medical and health sciences
Patient safety
0302 clinical medicine
Patient satisfaction
Health care
Humans
Medicine
Quality (business)
Cooperative Behavior
Accreditation
media_common
Pharmacology
Biological Products
business.industry
Health Policy
Gastroenterologists
Inflammatory Bowel Diseases
Biological Therapy
030220 oncology & carcinogenesis
Specialty pharmacy
Medication Persistence
Family medicine
030211 gastroenterology & hepatology
Pharmacy Service, Hospital
business
Subjects
Details
- ISSN :
- 15352900 and 10792082
- Volume :
- 76
- Database :
- OpenAIRE
- Journal :
- American Journal of Health-System Pharmacy
- Accession number :
- edsair.doi.dedup.....17a724301f56c5f7f41a2f80e1cf5584